The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

Diabetes Mellitus Clinical Trial

— Dates  

Official title:

The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01307904
• Other study ID #: UAEU Dates GI Study
• Status: Completed
• Phase: Phase 0
• First received: March 2, 2011
• Last updated: March 2, 2011
• Start date: March 2010
• Est. completion date: July 2010

Study information

• Verified date: March 2010
• Source: United Arab Emirates University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Arab Emirates:Office of Research and Graduate Studies,Faculty of Medicine& Health Sciences
• Study type: Interventional

Clinical Trial Summary

The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study.

The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items.

Description:

The United Arab Emirates (UAE) has transitioned rapidly over the last 40 years. This has lead to a dramatic increase in the prevalence of obesity, metabolic syndrome, dyslipidaemia, hypertension, prediabetes and diabetes. Daily consumption of dates is the norm.The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested equally in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study. The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items with potential health benefits for healthy and diabetic individuals alike.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 23
• Est. completion date: July 2010
• Est. primary completion date: March 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Adult

• Healthy or having controlled type 2 diabetes mellitus

Exclusion Criteria:

• Morbid obesity (BMI > 40)

• Presence of gastroenterological disorders

• Alimentary tract surgery

• A history of gastroenteritis in the prior six months

• Any disease that may affect glucose metabolism

• Alcohol intake

• Smoking

• Taking any medications (except metformin)

• Poorly uncontrolled diabetes (HbA1c > 8%)

• The presence of chronic diseases or the presence of acute illness

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)

Related Conditions & MeSH terms

• Diabetes Mellitus

Intervention

Other:
• Glucose
Each healthy and Diabetic volunteers received 50 grams of glucose
• Dates
Each healthy and diabetic volunteers received 50 grams equivalent of carbohydrates of each of the five selected dates, on five separate days.

Locations

Country	Name	City	State
United Arab Emirates	Internal Medicine Department, FMHS, UAE University	Al Ain	Abu Dhabi

Sponsors (2)

Lead Sponsor	Collaborator
United Arab Emirates University	Abu Dhabi Food Control Authority

Country where clinical trial is conducted

United Arab Emirates, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dates Glycemic Index	Measuring the composition of dates, selection of patients and carrying out the study	4 months	No